Arbro Pharmaceuticals Private Limited — Norfloxacin Exporter Profile
Indian Pharmaceutical Exporter · #5 for Norfloxacin · $377.7K export value · DGFT Verified
Arbro Pharmaceuticals Private Limited is the #5 Indian exporter of Norfloxacin with $377.7K in export value and 41 verified shipments. Arbro Pharmaceuticals Private Limited holds a 4.6% market share in Norfloxacin exports across 3 countries. The company exports 3 pharmaceutical products worth $952.2K across 2 therapeutic categories.
Arbro Pharmaceuticals Private Limited — Norfloxacin Export Profile: Buyers & Destinations
Where Does Arbro Pharmaceuticals Private Limited Export Norfloxacin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PAKISTAN | $203.9K | 20 | 54.0% |
| AFGHANISTAN | $163.6K | 19 | 43.3% |
| NIGERIA | $10.2K | 2 | 2.7% |
Arbro Pharmaceuticals Private Limited exports Norfloxacin to 3 countries. The largest destination is PAKISTAN accounting for 54.0% of Arbro Pharmaceuticals Private Limited's Norfloxacin shipments, followed by AFGHANISTAN (43.3%) and NIGERIA (2.7%). These destinations reflect Arbro Pharmaceuticals Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Norfloxacin from Arbro Pharmaceuticals Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| M/S. RAHMAN WALI LTD, | PAKISTAN | $85.3K | 6 |
| RAHMAN WALI LIMITED | PAKISTAN | $76.8K | 2 |
| M/S. HONEST HEALTH LTD. | AFGHANISTAN | $40.9K | 4 |
| M/S. MASEEH AMIRZAI LTD | PAKISTAN | $35.7K | 4 |
| M/S. AL MEDREICH KABUL LTD. | AFGHANISTAN | $34.5K | 4 |
| M/S. MASEEH AMIRZAI LTD. | PAKISTAN | $24.9K | 2 |
| MUSBAH TASNIM TRADING | AFGHANISTAN | $21.1K | 2 |
| MUSBAH TASNIM TRADING LTD. | PAKISTAN | $14.0K | 5 |
| M S HONEST HEALTH LIMITED OFFICE | PAKISTAN | $13.2K | 1 |
| MUSBAH TASNIM TRADING LIMITED | PAKISTAN | $12.2K | 3 |
Arbro Pharmaceuticals Private Limited supplies Norfloxacin to 13 buyers globally. The largest buyer is M/S. RAHMAN WALI LTD, (PAKISTAN), followed by RAHMAN WALI LIMITED (PAKISTAN) and M/S. HONEST HEALTH LTD. (AFGHANISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Norfloxacin Export Value and How Much Does Arbro Pharmaceuticals Private Limited Contribute?
India exported $4.9M worth of Norfloxacin through 1,394 shipments from 207 suppliers to 96 countries, serving 460 buyers globally. Arbro Pharmaceuticals Private Limited contributes $377.7K to this total, accounting for 4.6% of India's Norfloxacin exports. Arbro Pharmaceuticals Private Limited ships Norfloxacin to 3 countries through 13 buyers.
What Is the Average Shipment Value for Arbro Pharmaceuticals Private Limited's Norfloxacin Exports?
Arbro Pharmaceuticals Private Limited's average Norfloxacin shipment value is $9.2K per consignment, based on 41 shipments totaling $377.7K. The largest destination is PAKISTAN (54.0% of Arbro Pharmaceuticals Private Limited's Norfloxacin exports).
How Does Arbro Pharmaceuticals Private Limited Compare to Other Indian Norfloxacin Exporters?
Arbro Pharmaceuticals Private Limited ranks #5 among 207 Indian Norfloxacin exporters with a 4.6% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($1.2M), IPCA LABORATORIES LIMITED ($535.6K), PINNACLE LIFE SCIENCE PRIVATE LIMITED ($400.0K). Arbro Pharmaceuticals Private Limited processed 41 shipments to 3 destination countries.
What Norfloxacin Formulations Does Arbro Pharmaceuticals Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| NORKIN PLUS SUSPENSION NORFLOXACIN I.P | $76.8K | 2 |
| NORKIN PLUS SUSPENSION (NORFLOXACIN I.P | $25.9K | 2 |
| NORKIN PLUS SUSPENSION (NORFLOXACIN I.P100 MG + METRONIDAZOLE 100MG./5ML SUSPENSION) (AS PER INVOICE)NOS | $25.1K | 3 |
| Norkin Plus Suspension(Norfloxacin I.P100 mg + Metronidazole 100mg./5ml Suspension)B/N AU 24104,05,06,07, M/D 03/2025 | $23.8K | 1 |
| NORKIN PLUS SUSPENSION (NORFLOXACIN I.P100 MG + METRONIDAZOLE 100MG. (AS METRONIDAZOLE BENZOATE IP) /5ML SUSPENSION | $22.0K | 1 |
| NORKIN PLUS SUSPENSION(NORFLOXACIN I.P100MG+METRONIDAZOLE 100MG./5ML SUSPENSIO B/N: AU23087,88,89 M/D 02/2024 | $20.6K | 1 |
| Norkin Plus Suspension Norfloxacin I P100 mg Metronidazole 100mg 5ml Suspension B NO AU 25004 05 06 M DT 04 2025 | $14.6K | 1 |
| NORKIN-400 TABLETS (NORFLOXACIN TABLETS | $14.5K | 1 |
| NORKIN PLUS SUSPENSION NORFLOXACIN I.P100 MG + METRONIDAZOLE 100MG./5ML SUSPENSION BATCH NO.: AU23035 AU23036 | $13.2K | 1 |
| NORKIN PLUS SUSPENSION(NORFLOXACIN I.P100MG+METRONIDAZOLE 100MG.5ML SUSPENSION B/N.AU23089,90,91 M/D 02/2024 E/D 01/2027 | $13.0K | 1 |
Arbro Pharmaceuticals Private Limited exports 28 distinct Norfloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is NORKIN PLUS SUSPENSION NORFLOXACIN I.P with 2 shipments worth $76.8K.
Regulatory Requirements: Exporting Norfloxacin to Key Markets
What Arbro Pharmaceuticals Private Limited must comply with to export Norfloxacin to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Arbro Pharmaceuticals Private Limited Compare to Nearest Norfloxacin Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | IPCA LABORATORIES LIMITED | $535.6K | 20 | 5 | $26.8K |
| 2 | PINNACLE LIFE SCIENCE PRIVATE LIMITED | $400.0K | 8 | 3 | $50.0K |
| 5 | ARBRO PHARMACEUTICALS PRIVATE LIMITED ★ | $377.7K | 41 | 3 | $9.2K |
| 6 | EMCURE PHARMACEUTICALS LIMITED | $374.4K | 35 | 3 | $10.7K |
| 4 | MEDICAMEN BIOTECH LIMITED | $300.0K | 6 | 3 | $50.0K |
Arbro Pharmaceuticals Private Limited ranks #5 among 207 Indian Norfloxacin exporters. Average shipment value of $9.2K compared to the market average of $23.5K. The closest competitors by value are IPCA LABORATORIES LIMITED and PINNACLE LIFE SCIENCE PRIVATE LIMITED.
Which Indian Ports Ship Norfloxacin Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 186 | 13.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 140 | 10.0% |
| SAHAR AIR | 135 | 9.7% |
| DELHI AIR | 113 | 8.1% |
| NHAVA SHEVA SEA (INNSA1) | 109 | 7.8% |
| JNPT/ NHAVA SHEVA SEA | 67 | 4.8% |
| AHEMDABAD ICD | 41 | 2.9% |
| JNPT | 34 | 2.4% |
What Other Advanced Antibiotics Products Does Arbro Pharmaceuticals Private Limited Export?
Arbro Pharmaceuticals Private Limited also exports these advanced antibiotics products. Each links to the detailed product page.
About Arbro Pharmaceuticals Private Limited
Arbro Pharmaceuticals Private Limited exports 3 products worth $952.2K. Beyond Norfloxacin, top products include Trimethoprim, Aminophylline. View the complete Arbro Pharmaceuticals Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Norfloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Norfloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Arbro Pharmaceuticals Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 41 individual customs records matching Arbro Pharmaceuticals Private Limited exporting Norfloxacin, covering 28 formulations to 3 countries via 13 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 96+ countries, 460+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Norfloxacin Export Data from Arbro Pharmaceuticals Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Arbro Pharmaceuticals Private Limited's Norfloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Arbro Pharmaceuticals Private Limited
Full Company Profile →
3 products · $952.2K total trade · 2 categories
Norfloxacin Stats
Company Overview
Top Products by Arbro Pharmaceuticals Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Arbro Pharmaceuticals Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Norfloxacin. For current shipment-level data, contact TransData Nexus.